Holen Sie sich die Stockscreener-App
46.06
1.21%
0.55
Handel nachbörslich:
46.50
0.44
+0.96%
Boston Scientific Corp Aktie (BSX) Neueste Nachrichten
Boston Scientific earnings on deck as WATCHMAN slowdown looms By Investing.com - Investing.com Canada
UBS lowers Boston Scientific stock price target on valuation reset By Investing.com - Investing.com Canada
Boston Scientific Restructures Operations, Plans Workforce Cuts - Medical Product Outsourcing
Implicity’s Next-Generation ILR ECG Analyzer Earns FDA Clearance - GlobeNewswire Inc.
Canaccord reiterates Boston Scientific stock rating after restructuring - Investing.com
Boston Scientific Corp (BSX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Fears for Irish jobs as Boston Scientific plans global restructuring - Business Post
What To Expect From Boston Scientific’s (BSX) Q2 Earnings - Barchart.com
Boston Scientific Announces 2026 Global Restructuring Plan to Drive Cost Efficiencies and Growth - Minichart
Boston Scientific to restructure, cut costs by $500M annually - NBC Boston
Fed. Circ. Clears Boston Scientific In $49M Stent Patent Case - Law360
Boston Scientific unveils new restructuring plan, expects job cuts - Reuters
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Boston Scientific (NYSE: BSX) sets $700–$800 million restructuring with $500 million savings - Stock Titan
Boston Scientific Overturns $42M Patent Verdict - Intellectia AI
Boston Scientific Gets $42 Million Stent Patent Verdict Reversed - Bloomberg Law News
Here's How Much $100 Invested In Boston Scientific 15 Years Ago Would Be Worth Today - Benzinga
Boston Scientific Corp (BSX) Cash Flow - TradingKey
Boston Scientific Corporation (BSX) Options Chain - Yahoo! Finance Canada
Boston Scientific Corp (BSX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Boston Scientific Corp (BSX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Boston Scientific (BSX) Faces FDA Advisory Over Transcarotid Sys - GuruFocus
Boston Scientific (BSX) Faces Potential Device Risk Notification - GuruFocus
Boston Scientific Corp (BSX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Boston Scientific Corp (BSX) Institutional Confidence - TradingKey
Boston Scientific Corp (BSX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Electrosurgery Market Projected to Reach $11.59 Billion by 2031 as Demand for Minimally Invasive Procedures Rises - GlobeNewswire Inc.
BSX|Boston Scientific Corp|Price:45.500|Chg%:+1.250 - TradingKey
BSX|Boston Scientific Corp|Price:44.265|Chg%:+0.685 - TradingKey
Boston Scientific stock trades firm as cardiovascular revenue grows and TAVR momentum supports earni - AD HOC NEWS
Daily Brief Health Care: Boston Scientific, Mitesco Inc, Samsung Biologics and more - Smartkarma
Boston Scientific (BSX) Enrolls First Patients In Global Faraflex AFib Trial - Yahoo! Finance Canada
AAFMAA Wealth Management & Trust LLC's Boston Scientific Corp(BSX) Holding History - GuruFocus
Boston Scientific stock trades steady as recent earnings and cardiovascular portfolio shape investor - AD HOC NEWS
Boston Scientific Settles With Stryker In Spine Device IP Fight - Law360
Goldman Sachs Launches $510 Million Autocallable Notes Linked to Boston Scientific Stock Performance - Kalkine Media
Boston Scientific Corporation (BSX) Stock forecasts - Yahoo Finance UK
Boston Scientific, Stryker Settle Surgical Device Patent Dispute - Bloomberg Law News
Boston Scientific (BSX) Stock Still Looks Undervalued Following Its 58% Slump - Yahoo Finance
Boston Scientific stock trades steadily as device maker grows revenue and prepares for next earnings - Ad-hoc-news.de
Boston Scientific (BSX) Recalls Put Focus On Whether The Stock Still Looks Undervalued - Yahoo Finance
Boston Scientific (BSX) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance
Boston Scientific Corp. stock outperforms competitors despite losses on the day - MarketWatch
Boston Scientific's Q2 Earnings Coming Up: Buy, Hold or Sell the Stock? - Yahoo Finance
Boston Scientific stock advances on strong sales and margin gains - Ad-hoc-news.de
Boston Scientific to Combine Light Manufacturing, Global Distribution in Indiana Expansion - Assembly Magazine
Boston Scientific stock holds gains as cardiovascular revenue grows and new devices support long ter - Ad-hoc-news.de
Boston Scientific Corp at TD Cowen Healthcare Conference Transcript - GuruFocus
Boston Scientific Corp Investor Event at the Scientific Session of the American College of Cardiology Transcript - GuruFocus
Boston Scientific stock trades steady as latest earnings highlight growth and margin focus - ad-hoc-news.de
The Bull Case For Boston Scientific (BSX) Could Change Following Global Recall Of CRE Endoscopy Devices - simplywall.st
Boston Scientific stock trades steady as cardiovascular and neuromodulation growth supports earnings - ad-hoc-news.de
Boston Scientific Corp. stock underperforms Friday when compared to competitors - MarketWatch
Boston Scientific stock trades steadily as Q1 2026 growth and cardiology portfolio underpin valuatio - Ad Hoc News
Boston Scientific Corp. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Boston Scientific Expands Medical Device R&D in Ireland With €75 Million Investment - Assembly Magazine
Boston Scientific (BSX): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance
Boston Scientific stock hits 52-week low at 42.24 USD By Investing.com - Investing.com South Africa
Boston Scientific stock hits 52-week low at 42.24 USD - Investing.com
Boston Scientific (BSX) Faces WATCHMAN Slowdown But Analysts Still See Upside - Yahoo Finance
Why Is Boston Scientific (NYSE:BSX) Growing Medical Technology? - Kalkine Media
Boston Scientific Corp (BSX) Shares Fall 4.5% -- What GF Score o - GuruFocus
Boston Scientific Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Boston Scientific Slides as WATCHMAN Slowdown Concerns and Fresh Target Cuts Weigh on Shares - Quiver Quantitative
Are Boston Scientific’s (BSX) Sterile-Packaging Recalls Reframing the Narrative on Quality and Regulatory Risk? - Yahoo Finance
Boston Scientific stock reflects steady medtech demand - ad-hoc-news.de
0.77%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):